Diabetes and ADHD drugs to be tested on Alzheimer’s patients in new study

• Diabetes and ADHD medications are being simultaneously tested as potential Alzheimer's treatments, potentially accelerating drug development timelines for this common dementia type
• Repurposing existing drugs may offer a faster, more cost-effective route to new therapeutic options compared to traditional drug development pathways
• This approach reflects growing research interest in metabolic and neurological mechanisms that may underlie Alzheimer's disease pathogenesis

Drugs will be tested simultaneously, which it's hoped will speed up the process of finding new treatments for this common type of dementia.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.